FDA Inspection 1197691 — Oklahoma Blood Institute Arkansas Blood Institute - North Little Rock
The FDA completed an inspection of Oklahoma Blood Institute Arkansas Blood Institute - North Little Rock on Jan 25, 2023 in North Little Rock, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 25, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- North Little Rock, AR (United States)